These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24025662)

  • 1. A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes.
    Hernández Alava M; Wailoo A; Wolfe F; Michaud K
    Med Decis Making; 2014 Oct; 34(7):919-30. PubMed ID: 24025662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis.
    Wolfe F; Michaud K; Wallenstein G
    J Rheumatol; 2010 Aug; 37(8):1615-25. PubMed ID: 20551106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.
    Kim HL; Kim D; Jang EJ; Lee MY; Song HJ; Park SY; Cho SK; Sung YK; Choi CB; Won S; Bang SY; Cha HS; Choe JY; Chung WT; Hong SJ; Jun JB; Kim J; Kim SK; Kim TH; Kim TJ; Koh E; Lee H; Lee HS; Lee J; Lee SS; Lee SW; Park SH; Shim SC; Yoo DH; Yoon BY; Bae SC; Lee EK
    Rheumatol Int; 2016 Apr; 36(4):505-13. PubMed ID: 26849891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden.
    Wallman JK; Eriksson JK; Nilsson JÅ; Olofsson T; Kristensen LE; Neovius M; Geborek P
    J Rheumatol; 2016 Jul; 43(7):1292-9. PubMed ID: 27252420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain.
    Carreño A; Fernández I; Badia X; Varela C; Roset M
    Value Health; 2011 Jan; 14(1):192-200. PubMed ID: 21211502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values.
    Hernández Alava M; Wailoo AJ; Ara R
    Value Health; 2012 May; 15(3):550-61. PubMed ID: 22583466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
    Lillegraven S; Kristiansen IS; Kvien TK
    Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal predictive ability of mapping models: examining post-intervention EQ-5D utilities derived from baseline MHAQ data in rheumatoid arthritis patients.
    Kontodimopoulos N; Bozios P; Yfantopoulos J; Niakas D
    Eur J Health Econ; 2013 Apr; 14(2):307-14. PubMed ID: 22252308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis.
    Hernández Alava M; Wailoo A; Wolfe F; Michaud K
    Rheumatology (Oxford); 2013 May; 52(5):944-50. PubMed ID: 23339232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping from the Health Assessment Questionnaire to the EQ-5D: the impact of different algorithms on cost-effectiveness results.
    Pennington B; Davis S
    Value Health; 2014 Dec; 17(8):762-71. PubMed ID: 25498771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients.
    Karlsson JA; Nilsson JÅ; Neovius M; Kristensen LE; Gülfe A; Saxne T; Geborek P
    Ann Rheum Dis; 2011 Dec; 70(12):2163-6. PubMed ID: 21859684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis.
    Hernández-Alava M; Pudney S
    J Health Econ; 2017 Sep; 55():139-152. PubMed ID: 28778350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping a patient-reported functional outcome measure to a utility measure for comparative effectiveness and economic evaluations in older adults with low back pain.
    Rundell SD; Bresnahan BW; Heagerty PJ; Comstock BA; Friedly JL; Jarvik JG; Sullivan SD
    Med Decis Making; 2014 Oct; 34(7):873-83. PubMed ID: 24829274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
    Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
    PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores.
    Kay S; Ferreira A
    Ophthalmic Epidemiol; 2014 Apr; 21(2):66-78. PubMed ID: 24568628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry.
    Buitinga L; Braakman-Jansen LM; Taal E; Kievit W; Visser H; van Riel PL; van de Laar MA
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):826-32. PubMed ID: 22262513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA database.
    Hoshi D; Tanaka E; Igarashi A; Inoue E; Kobayashi A; Sugimoto N; Shidara K; Sato E; Seto Y; Nakajima A; Momohara S; Taniguchi A; Tsutani K; Yamanaka H
    Mod Rheumatol; 2016; 26(1):40-5. PubMed ID: 26052801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort.
    Gaujoux-Viala C; Fautrel B; Guillemin F; Flipo RM; Bourgeois P; Rat AC
    Rheumatology (Oxford); 2013 May; 52(5):832-8. PubMed ID: 23093721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire.
    Barra L; Pope JE; Payne M
    J Rheumatol; 2009 Jul; 36(7):1421-8. PubMed ID: 19487267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.